Debugging Metformin: The "Diabetes Drug" Reversing Brain Aging?
For more than half a century, the medical community believed that Metformin worked primarily
by reducing glucose output in the liver. However, a major recent systemic breakdown analysis has
radically shifted this traditional paradigm.
Research published in Science Advances (2025/2026) has revealed that Metformin travels directly to
the ventromedial hypothalamus (VMH) in the brain. It shuts down a metabolic protein
known as Rap1, essentially rewriting your body's metabolic code directly from the
master control center.
Because of this newly understood pathway, Metformin is now being firmly evaluated as a
gerotherapeutic—a compound capable of targeting aging. In fact, clinical data
indicate women treated with Metformin have roughly a 30% lower risk of dying before
age 90 compared to those on other treatments.
📑 Scientific Sources:
Science Advances (2025) – Low-dose metformin requires brain Rap1 for its antidiabetic action
ScienceAlert (March 2026)
